CBDG — THC Farmaceuticals Cashflow Statement
0.000.00%
Last trade - 00:00Consumer DefensivesHighly SpeculativeMicro Cap
- $0.27m
- $0.18m
- $0.01m
Annual cashflow statement for THC Farmaceuticals, fiscal year end - September 30th, USD millions except per share, conversion factor applied.
2013 September 30th | 2014 September 30th | 2020 September 30th | 2021 September 30th | 2022 September 30th | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | 10-K | 10-K | ARS | PROSPECTUS | PROSPECTUS |
| Standards: | USG | USG | — | — | — |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | -0.024 | -0.031 | -0.121 | -0.017 | 0.427 |
| Depreciation | |||||
| Non-Cash Items | 0 | — | 0.088 | 0.006 | -0.026 |
| Unusual Items | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | 0.004 | 0.011 | 0.03 | -0.002 | -0.099 |
| Change in Accounts Receivable | |||||
| Change in Accounts Payable | |||||
| Change in Accrued Expenses | |||||
| Cash from Operating Activities | -0.019 | -0.019 | -0.002 | -0.012 | 0.305 |
| Capital Expenditures | — | — | — | 0 | -0.625 |
| Purchase / Acquisition of Intangibles | |||||
| Other Investing Cash Flow Items | 0 | — | — | 0 | 0.645 |
| Sale of Fixed Assets | |||||
| Sale/Maturity of Investment | |||||
| Cash from Investing Activities | 0 | — | — | 0 | 0.02 |
| Financing Cash Flow Items | — | — | — | 0 | -0.001 |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 0.017 | 0.019 | 0.002 | 0.028 | -0.343 |
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | -0.002 | 0 | 0 | 0.016 | -0.017 |